Reaferon-ES lyophilisate for preparation of solution for injection and topical application 0.5 mln IU, vial 5pcs pack carton pac

The drug has antiviral, antitumour, immunomodulatory activity. Therefore, the drug is mainly used in the therapy of severe infectious and oncological diseases.
The main advantage of Reaferon-E®C is that the cost of the course of treatment is many times cheaper compared to imported and Russian analogues. The doses of Reaferon-ES® recommended in the instructions for use are 2-5 times lower than those of some foreign interferons, although the clinical effect is the same
Powder or porous mass of white colour. Hygroscopic. When diluted, a colourless transparent or slightly opalescent solution is formed.